Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06866483 · ClinicalTrials.gov registry record
Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment
A clinical trial of Myasthenia Gravis and Neuromuscular Manifestations, sponsored by ZS Associates.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06866483 is a study of Myasthenia Gravis and Neuromuscular Manifestations that is actively recruiting participants, run by ZS Associates. The registered enrollment target is 1,000 participants, above the 160-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (525% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06866483, a study of Myasthenia Gravis and Neuromuscular Manifestations, is actively recruiting participants, sponsored by ZS Associates.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-assessment tool in encouraging undiagnosed participants, recruited through a social media campaign, to seek medical evaluation for suspected myasthenia gravis (MG).
Conditions Studied
Interventions
- BEHAVIORAL Social media recruitment
- BEHAVIORAL Self-Assessment
- BEHAVIORAL Follow-up
Study Locations (1)
Illinois
- ZS Associates - Evanston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-02-26 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06866483
The ClinicalTrials.gov registry entry for NCT06866483 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 160-participant average among 32 other Myasthenia Gravis trials with a reported enrollment target (525% higher). The listed sponsor is ZS Associates, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Myasthenia Gravis appearing as the primary indexed condition, and to 3 interventions - of which Social media recruitment is the first listed.
NCT06866483 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT06866483 about?
NCT06866483 is a clinical study titled "Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment". This study expands and validates the pilot study NCT06381284. It is a fully remote, site-less, prospective, observational study enrolling adults in the United States (excluding U.S. territories) with undiagnosed neuromuscular symptoms. The primary objective is to determine the validity of a self-ass...
What is the current status of trial NCT06866483?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-02-26. Estimated completion is 2025-12-31.
What conditions does trial NCT06866483 study?
This clinical trial studies the following conditions: Myasthenia Gravis, Neuromuscular Manifestations, Neuromuscular Disease.
What interventions are being tested in trial NCT06866483?
The interventions under investigation include: Social media recruitment (BEHAVIORAL), Self-Assessment (BEHAVIORAL), Follow-up (BEHAVIORAL).
Who is sponsoring clinical trial NCT06866483?
This trial is sponsored by ZS Associates, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06866483 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myasthenia Gravis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
RECRUITING
-
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
RECRUITING · Phase 3
-
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
RECRUITING
-
Light vs. Moderate Intensity Exercise in Individuals With Myasthenia Gravis
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.